Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD

被引:145
|
作者
Sipponen, Taina [1 ]
Nuutinen, Hannu [1 ]
Turunen, Ulla [1 ]
Farkkila, Martti [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Div Gastroenterol, Dept Med, Helsinki 00029, Finland
关键词
CDEIS; Crohn's disease; endoscopic activity; endoscopic monitoring; SES-CD; FECAL CALPROTECTIN; CLINICAL-TRIALS; ACTIVITY INDEX; END-POINTS; INFLIXIMAB; THERAPY; SCORE; LACTOFERRIN; VALIDATION; ADULTS;
D O I
10.1002/ibd.21300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Few data exist of prospective parallel scoring of the validated endoscopic scores in Crohn's disease (CD), Crohn's Disease Index of Severity (CDEIS), and Simple Endoscopic Score for Crohn's Disease (SES-CD). Methods: Both the CDEIS and the SES-D were scored immediately after each endoscopy of 86 CD patients referred for ileocolonoscopy in a cross-sectional study. Furthermore, after CD therapy, 32 CD patients underwent a follow-up endoscopy with scoring of the CDEIS and SES-CD. Endoscopic scorings were graded as inactive, mild, moderate, or severe. Clinical activity was assessed with the Crohn's Disease Activity Index (CDAI) and serum C-reactive protein (CRP) was measured. Results: The SES-CD correlated with the CDEIS significantly (Spearman's r = 0.938, P < 0.0001). Weaker correlations were detected between the SES-CD and the CDAI (r = 0.473) or CRP (r = 0.525, both P < 0.0001). Grading of SES-CD from inactive to severe correlated significantly with grading of the CDEIS (r = 0.859, P < 0.0001). Changes between baseline and follow-up endoscopy scores correlated significantly (r = 0.828 between delta-CDEIS and delta-SES-CD, P < 0.001), but failed to correlate with delta-CDAI or delta-CRP (all P > 0.05). Conclusions: Both validated endoscopic scores, the CDEIS and SES-CD, and their changes during CD therapy demonstrated a close correlation. For scoring of endoscopic activity in clinical routine, the SES-CD could replace the CDEIS.
引用
收藏
页码:2131 / 2136
页数:6
相关论文
共 50 条
  • [21] Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
    Maria Vazquez-Moron, Juan
    Pallares-Manrique, Hector
    Machancoses, Francisco H.
    Ramos-Lora, Manuel
    Ruiz-Frutos, Carlos
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (02) : 130 - 136
  • [22] Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease
    Goutorbe, F.
    Goutte, M.
    Minet-Quinard, R.
    Boucher, A-L.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (12) : 1113 - 1119
  • [23] Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers
    Stoppino, Luca Pio
    Della Valle, Nicola
    Rizzi, Stefania
    Cleopazzo, Elsa
    Centola, Annarita
    Iamele, Donatello
    Bristogiannis, Christos
    Stoppino, Giuseppe
    Vinci, Roberta
    Macarini, Luca
    BMC MEDICAL IMAGING, 2016, 16
  • [24] Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
    af Bjorkesten, Clas-Goran
    Nieminen, Urpo
    Turunen, Ulla
    Arkkila, Perttu
    Sipponen, Taina
    Farkkila, Martti
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 528 - 537
  • [25] Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease
    Kucharski, Marcin
    Karczewski, Jacek
    Mankowska-Wierzbicka, Dorota
    Karmelita-Katulska, Katarzyna
    Kaczmarek, Elhbieta
    Iwanik, Katarzyna
    Rzymski, Piotr
    Grzymislawski, Marian
    Linke, Krzysztof
    Dobrowolska, Agnieszka
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [26] Monitoring Crohn's disease activity: endoscopy, fecal markers and computed tomography enterography
    Lopes, Susana
    Andrade, Patricia
    Afonso, Joana
    Cunha, Rui
    Rodrigues-Pinto, Eduardo
    Ramos, Isabel
    Macedo, Guilherme
    Magro, Fernando
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [27] Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease
    Zittan, Eran
    Kabakchiev, Boyko
    Kelly, Orlaith B.
    Milgrom, Raquel
    Nguyen, Geoffrey C.
    Croitoru, Kenneth
    Steinhart, Hillary
    Silverberg, Mark S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05) : 543 - 548
  • [28] Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
    Reinisch, Walter
    Panaccione, Remo
    Bossuyt, Peter
    Baert, Filip
    Armuzzi, Alessandro
    Hebuterne, Xavier
    Travis, Simon
    Danese, Silvio
    Sandborn, William J.
    Schreiber, Stefan
    Berg, Sofie
    Zhou, Qian
    Kligys, Kristina
    Neimark, Ezequiel
    Suleiman, Ahmed A.
    D'Haens, Geert
    Colombel, Jean-Frederic
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (10) : 1562 - 1571
  • [29] Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location
    Buisson, Anthony
    Mak, Wing Yan
    Andersen, Michael J.
    Lei, Donald
    Pekow, Joel
    Cohen, Russell D.
    Kahn, Stacy A.
    Pereira, Bruno
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) : 1008 - 1016
  • [30] Predicting Endoscopic Disease Activity in Crohn's Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index)
    Minderhoud, Itta M.
    Steyerberg, Ewout W.
    van Bodegraven, Ad A.
    van der Woude, C. Janneke
    Hommes, Daniel W.
    Dijkstra, Gerard
    Fidder, Herma H.
    Schwartz, Matthijs P.
    Oldenburg, Bas
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (10) : 2453 - 2459